Met Life Investment Management, LLC Applied Molecular Transport Inc. Transaction History

Met Life Investment Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$5.63 - $13.88 $48,265 - $118,993	-8,573 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$13.23 - $26.05 $113,420 - $223,326	8,573 New	8,573 $119,000
Q3 2021 Jun 21, 2023	BUY	$25.87 - $46.61 $221,783 - $399,587	8,573 New	8,573 $221,000
Q2 2021 Jun 21, 2023	BUY	$39.76 - $64.31 $340,862 - $551,329	8,573 New	8,573 $392,000
Q1 2021 May 17, 2024	BUY	$30.5 - $74.14 $261,476 - $635,602	8,573 New	8,573 $377,000

Q1 2021 Jun 26, 2023	BUY	$30.5 - $74.14 $261,476 - $635,602	8,573 New	8,573 $377 Million
Q1 2021 Mar 22, 2023	BUY	$30.5 - $74.14 $90,249 - $219,380	2,959 Added 52.71%	8,573 $377,000
Q1 2021 May 14, 2021	BUY	$30.5 - $74.14 $90,249 - $219,380	2,959 Added 52.71%	8,573 $377,000
Q4 2020 Jun 22, 2023	BUY	$29.39 - $35.0 $164,995 - $196,490	5,614 New	5,614 $172,000
Q3 2020 May 24, 2024	BUY	$20.49 - $33.58 $115,030 - $188,518	5,614 New	5,614 $179 Million
Q3 2020 Jun 26, 2023	BUY	$20.49 - $33.58 $115,030 - $188,518	5,614 New	5,614 $178,000
Q3 2020 Mar 22, 2023	BUY	$20.49 - $33.58 $115,030 - $188,518	5,614 New	5,614 $178,000
Q3 2020 Nov 13, 2020	BUY	$20.49 - $33.58 $115,030 - $188,518	5,614 New	5,614 $179,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.